2012 site selection report

The US recession might be over, but the obstacles facing the biopharmaceutical industry are still plentiful. There’s the eurozone debt crisis, US healthcare reform, an inefficient FDA, and the list goes on. Combined, these factors create a landscape of uncertainty […]

Read More

Some good news on drug shortage–finally

The ongoing crisis in short-supply drugs, which went from background noise to a top-level problem for many hospital networks over the past year has not been “fixed,” by any means. The current list, available at the Am. Soc. of Health-System […]

Read More

A scientific approach to site selection

The global drug and pharmaceutical market continues to grow, but not all geographic locations deliver equal value. Incremental revenue from mature markets continues to decline, while emerging markets continue to grow. This trend is creating a change in how companies […]

Read More

A conversation with Chris Smith, H. D. Smith

Chairman Dale Smith, left, and president, Chris Smith H. D. Smith, founded in 1954, is today the largest privately-held wholesaler in the US. Based in Springfield, IL, the company services clients nationally from seven full-line distribution centers, its specialty subsidiary, […]

Read More